MRI biopsy is increasing broad acknowledgment as an aide to mammography and sonography in the recognition and determination of malignancy. Traditional biopsy devices can be supplemented with cutting edge imaging technologies, for example, MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy, CT sweep, and others to perform biopsy methodology with precision and minimal invasiveness.
These coordinated techniques are essential to perform biopsies in critical areas of the body, for example, the lungs, liver, and kidney.
Increasing incidences of cancer including breast, prostate, & lung, and rapid technological improvements have been stimulating the growth of the MRI compatible biopsy devices market. Moreover, increase in attention for the prognosis of chronic diseases including breast cancers and lung cancers is also increasing the demand for included biopsy technology along with MRI-guided biopsy were predicting the increase of MRI compatible biopsy devices market.
On the opposite, using advanced biopsy devices in developing nations continues to be restrained because of high price, unawareness for the diagnosis of chronic illnesses, and shortage of technical understanding in all likelihood to be restraining factor for the growth of MRI compatible biopsy devices market.
MRI-guided vacuum-assisted biopsy has been executed efficiently for some of years in Europe and recently within the United States with achievement charges ranging from 94-98%. Advantages of MRI-guided vacuum-assisted core biopsy include lower hazard, morbidity, and price compared with surgical biopsy; more accuracy than first-class-needle aspiration are the other factors which are likely to fuel the growth of MRI compatible biopsy devices market.
However, with the accelerated adoption of non–invasive methods, the system is now being encouraged for low-danger patients as well. This additionally reduces the stress stages and recovery period of the sufferers. There are enormous novel cancer diagnostic and biopsy techniques which are added and are evidencing significant increase price because of increased consciousness among patients are the other factors for the growth of MRI compatible biopsy devices.
Rising number of breast cancer screening applications and growing demand for minimally invasive surgical procedures are driving the growth of the MRI compatible biopsy devices market. On the basis of procedure type, the MRI compatible biopsy devices market is segmented into vacuum-assisted, middle needle, fine needle aspiration, and surgical biopsy.
Vacuum-assisted biopsy is expected to be the fastest growing process at some stage in the forecast length. On basis of product type, MRI compatible biopsy devices Biopsy needles market is expected to be fastest growing phase during forecast period.
On the basis of end-user, the MRI compatible biopsy devices market is segmented into hospitals, diagnostic facilities, and others, where diagnostic centers account for the largest demand for MRI compatible biopsy device, globally.
Globally, North America is the largest market for the MRI compatible biopsy devices, because of growing prevalence of breast most cancers, developing ageing populace, high healthcare expenditure, financial increase, and expanding personal healthcare zone.
Furthermore, growing awareness of newly evolved technologies, growing per capita earnings, and growing wide variety of United States Food and Drug Administration (USFDA) approvals for breast biopsy devices, are a number of the alternative elements fueling the growth of the MRI compatible biopsy devices market.
Europe represents the second prominent market in the MRI compatible biopsy devices. The MRI compatible biopsy devices market in the Asia Pacific is anticipated to register comparatively fast growth in terms of revenue over the coming years due to the rising cancer population, advancement in technology, increasing awareness and education among people regarding minimal invasive techniques for the diagnosis of malignancy.
Some of the other key players operating in the breast biopsy devices industry are Danaher Corporation, Argon Medical Devices Inc., Becton, Dickinson and Company, Sterylab S.R.L., Scion Medical Technologies LLC, Siemens AG, Medtronic plc, and Cook Medical LLC.
The research report presents a comprehensive assessment of the MRI compatible biopsy devices market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to MRI compatible biopsy devices market segments such as geographies, application, and industry.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
MRI compatible biopsy devices market is segmented based on Products, Procedure, end user and regions.
Based on Products, MRI compatible biopsy devices market is segmented into
Based on Procedure, MRI compatible biopsy devices market is segmented into
Based on end user, MRI compatible biopsy devices market is segmented into
Explore Similar Insights
MRI Compatible Biopsy Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
